Frequency Therapeutics, Inc. (FREQ)

NASDAQ: FREQ · IEX Real-Time Price · USD
1.11
-0.16 (-12.60%)
At close: May 20, 2022 4:00 PM
1.15
0.04 (3.60%)
After-hours:May 20, 2022 7:38 PM EDT

Income Statement (Quarterly)

Millions USD. Fiscal year is Jan - Dec.
Quarter Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Revenue
0009.424.659.9511.258.527.264.7124.240000
Revenue Growth (YoY)
---10.49%-35.97%111.30%-53.60%--------
Gross Profit
0009.424.659.9511.258.527.264.7124.240000
Selling, General & Admin
9.488.619.339.59.748.46.515.966.2554.273.12.472.41.51
Research & Development
13.7812.7515.6617.415.1111.8310.158.766.676.25.223.923.452.923.55
Other Operating Expenses
0000000000160000
Operating Expenses
23.2621.3624.9926.924.8520.2316.6714.7212.9211.225.497.025.925.335.06
Operating Income
-23.26-21.36-24.99-17.48-20.2-10.28-5.42-6.2-5.66-6.49-1.25-7.02-5.92-5.33-5.06
Interest Expense / Income
0.080.10.010.060.19-0.03-0.07-0.18-0.71-0.94-0.62-0.12-0.10.010.06
Other Expense / Income
0.030.040.150.1-0.020.01-0.02-0-0.07-0.05-0.05-0.050.010.110.02
Pretax Income
-23.37-21.5-25.15-17.65-20.38-10.26-5.33-6.02-4.88-5.49-0.58-6.85-5.83-5.45-5.14
Income Tax
0.01000.010-0.030.020.010.04000000
Net Income
-23.39-21.5-25.16-17.66-20.38-10.23-5.34-6.03-4.91-5.49-0.58-6.85-5.83-5.45-5.14
Preferred Dividends
0000000000.041.010000
Net Income Common
-23.39-21.5-25.16-17.66-20.38-10.23-5.34-6.03-4.91-5.53-1.59-6.85-5.83-5.45-5.14
Shares Outstanding (Basic)
353534343434333131922222
Shares Outstanding (Diluted)
353534343434333131922222
Shares Change
2.04%2.29%4.16%10.21%10.52%291.06%1428.87%1449.42%1616.82%411.54%37.29%----
EPS (Basic)
-0.67-0.63-0.73-0.52-0.60-0.31-0.16-0.19-0.164.88-0.73-3.42-3.24-3.24-3.26
EPS (Diluted)
-0.67-0.63-0.73-0.52-0.60-0.31-0.16-0.19-0.164.88-0.73-3.42-3.24-3.24-3.26
Free Cash Flow Per Share
-0.50-0.52-0.45-0.57-0.76-0.57-0.35-0.36-0.31-3.4934.40-2.25-3.68-2.93-
Gross Margin
---100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%----
Operating Margin
----185.65%-434.29%-103.29%-48.17%-72.74%-77.85%-137.78%-5.17%----
Profit Margin
----187.49%-438.08%-102.83%-47.49%-70.69%-67.63%-116.65%-2.37%----
Free Cash Flow Margin
----208.91%-559.39%-193.48%-104.30%-131.07%-133.62%-640.54%307.06%----
Effective Tax Rate
-0.05%-0.01%-0.01%-0.06%0.00%0.24%-0.28%-0.12%-0.78%0.00%0.00%0.00%0.00%0.00%0.00%
EBITDA
-21.97-20.09-24.33-16.53-19.51-9.73-5.01-5.86-5.3-6.21-0.99-6.76-5.76-5.23-
EBITDA Margin
----175.49%-419.57%-97.74%-44.53%-68.78%-72.89%-131.88%-4.06%----
EBIT
-23.29-21.4-25.14-17.58-20.18-10.29-5.4-6.2-5.59-6.44-1.2-6.97-5.93-5.44-5.07
EBIT Margin
----186.70%-433.93%-103.41%-48.01%-72.70%-76.89%-136.65%-4.95%----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).